In Silico Simulation of Corticosteroids Effect on an NFkB- Dependent Physicochemical Model of Systemic Inflammation
暂无分享,去创建一个
Ioannis P. Androulakis | Panagiota T. Foteinou | Steve E. Calvano | Stephen F. Lowry | I. Androulakis | S. Calvano | S. Lowry | P. T. Foteinou
[1] Panagiota T. Foteinou,et al. An indirect response model of endotoxin-induced systemic inflammation , 2007 .
[2] Young Sang Kim,et al. Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins. , 2007, Molecules and cells.
[3] Chien-Chang Lee,et al. Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. , 2007 .
[4] Richard R. Almon,et al. Third-generation model for corticosteroid pharmacodynamics: Roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver , 1995, Journal of Pharmacokinetics and Biopharmaceutics.
[5] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[6] David J Klinke,et al. Modulating temporal control of NF-kappaB activation: implications for therapeutic and assay selection. , 2008, Biophysical journal.
[7] S. Calvano,et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. , 1993, Journal of immunology.
[8] Gilles Clermont,et al. A MATHEMATICAL SIMULATION OF THE INFLAMMATORY RESPONSE TO ANTHRAX INFECTION , 2008, Shock.
[9] C. Galanos,et al. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.
[10] J. Rubin,et al. In Silico and In Vivo Approach to Elucidate the Inflammatory Complexity of CD14-deficient Mice , 2006, Molecular medicine.
[11] John D. Storey,et al. Significance analysis of time course microarray experiments. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Sprung,et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. , 1987, The New England journal of medicine.
[13] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[14] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[15] K. Tracey,et al. Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. , 1989, Annals of surgery.
[16] M. Meisner,et al. Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. , 1998, The Journal of pharmacology and experimental therapeutics.
[17] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.
[18] M. Karin,et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. , 1995, Science.
[19] Shuzhong Zhang,et al. Pharmacodynamics and Pharmacogenomics of Diverse Receptor-Mediated Effects of Methylprednisolone in Rats Using Microarray Analysis , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[20] Meindert Danhof,et al. Disease System Analysis: Basic Disease Progression Models in Degenerative Disease , 2005, Pharmaceutical Research.
[21] D. Rifkind. Prevention by polymyxin B of endotoxin lethality in mice , 1967, Journal of bacteriology.
[22] U. Senftleben. NF-kappaB in critical diseases: a bad guy? , 2003, Intensive care medicine.
[23] David S. Broomhead,et al. Sensitivity analysis of parameters controlling oscillatory signalling in the NF-/sub K/Bpathway: the roles of IKK and I/sub K/B/sub alpha/ , 2004 .
[24] J. Briegel,et al. Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. , 2001, Journal of the American Society of Nephrology : JASN.
[25] Gilles Clermont,et al. IN SILICO MODELS OF ACUTE INFLAMMATION IN ANIMALS , 2006, Shock.
[26] Mehmet Toner,et al. Application of genome-wide expression analysis to human health and disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[28] Djillali Annane,et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis , 2004, BMJ : British Medical Journal.
[29] Jin Y. Jin,et al. Pharmacogenomic responses of rat liver to methylprednisolone: An approach to mining a rich microarray time series , 2005, The AAPS Journal.
[30] Richard R. Almon,et al. Fourth-Generation Model for Corticosteroid Pharmacodynamics: A Model for Methylprednisolone Effects on Receptor/Gene-Mediated Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[31] John D. Storey,et al. A network-based analysis of systemic inflammation in humans , 2005, Nature.
[32] T. Iwaya,et al. Randomized Study of the Benefits of Preoperative Corticosteroid Administration on the Postoperative Morbidity and Cytokine Response in Patients Undergoing Surgery for Esophageal Cancer , 2002, Annals of surgery.
[33] A. Hoffmann,et al. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.
[34] P. Nyström,et al. The systemic inflammatory response syndrome: definitions and aetiology. , 1998, The Journal of antimicrobial chemotherapy.
[35] D. Broomhead,et al. Sensitivity analysis of parameters controlling oscillatory signalling in the NF-kappaB pathway: the roles of IKK and IkappaBalpha. , 2004, Systems biology.
[36] Yaniv Almog,et al. Corticosteroids in sepsis: a new concept for an old drug. , 2003, The Israel Medical Association journal : IMAJ.
[37] Jin Y. Jin,et al. Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene Microarrays , 2003, Journal of Pharmacology and Experimental Therapeutics.
[38] G. Meduri,et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. , 1998, JAMA.
[39] William J Jusko,et al. Diversity of mechanism-based pharmacodynamic models. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[40] R. Carmody,et al. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. , 2007, Cellular & molecular immunology.
[41] J. Cidlowski,et al. Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.
[42] W. Jusko. Receptor-mediated pharmacodynamics of corticosteroids. , 1994, Progress in clinical and biological research.
[43] U. Senftleben. NF-κB in critical diseases: a bad guy? , 2003, Intensive Care Medicine.
[44] G. Clermont,et al. In silico design of clinical trials: A method coming of age , 2004, Critical care medicine.
[45] Debra C DuBois,et al. A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens. , 2007, Endocrinology.
[46] D. DuBois,et al. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[47] R. Lefering,et al. Steroid controversy in sepsis and septic shock: a meta-analysis. , 1995, Critical care medicine.
[48] J. Rubin,et al. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. , 2006, Journal of theoretical biology.
[49] Nigel Mackman,et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C , 2007, The Journal of experimental medicine.
[50] Debra C DuBois,et al. Corticosteroid-regulated genes in rat kidney: mining time series array data. , 2005, American journal of physiology. Endocrinology and metabolism.
[51] D. Annane,et al. Corticosteroids for treating severe sepsis and septic shock. , 2004, The Cochrane database of systematic reviews.
[52] F. Holsboer,et al. Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. , 1994, Endocrinology.
[53] Gary An,et al. Translational Systems Biology of Inflammation , 2008, PLoS Comput. Biol..
[54] Kim Sneppen,et al. Minimal model of spiky oscillations in NF-kappaB signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[55] T. Hawn,et al. Differential Constitutive and Cytokine-Modulated Expression of Human Toll-like Receptors in Primary Neutrophils, Monocytes, and Macrophages , 2008, International journal of medical sciences.
[56] C Ronco,et al. Recent insights into the pathogenesis of severe sepsis. , 2005, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[57] Ioannis P. Androulakis,et al. Bioinformatics analysis of the early inflammatory response in a rat thermal injury model , 2007, BMC Bioinformatics.
[58] D. Lauffenburger,et al. Analysis of a lumped model for tissue inflammation dynamics. , 1981, Mathematical biosciences.
[59] Panagiota T. Foteinou,et al. Modeling endotoxin-induced systemic inflammation using an indirect response approach. , 2009, Mathematical biosciences.
[60] D. Hume,et al. Inflammation suppressor genes: please switch out all the lights , 2005, Journal of leukocyte biology.
[61] G. Clermont,et al. THE ACUTE INFLAMMATORY RESPONSE IN DIVERSE SHOCK STATES , 2005, Shock.
[62] W. Jusko,et al. Mathematical Formalism for the Properties of Four Basic Models of Indirect Pharmacodynamic Responses , 1997, Journal of pharmacokinetics and biopharmaceutics.
[63] J. Dean,et al. Control of the expression of inflammatory response genes. , 2003, Biochemical Society symposium.
[64] M. Abreu,et al. TLR4 and MD-2 Expression Is Regulated by Immune-mediated Signals in Human Intestinal Epithelial Cells* , 2002, The Journal of Biological Chemistry.
[65] Ryan Zurakowski,et al. A model predictive control based scheduling method for HIV therapy. , 2006, Journal of theoretical biology.
[66] R. Ramakrishnan,et al. Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[67] Peter A. Ward,et al. Novel strategies for the treatment of sepsis , 2003, Nature Medicine.
[68] K. Sneppen,et al. Minimal model of spiky oscillations in NF-κB signaling , 2006 .
[69] J. Marshall,et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence , 2002, Critical care.
[70] G. Clermont,et al. The dynamics of acute inflammation. , 2004, Journal of theoretical biology.
[71] J. Marshall,et al. Let the Cells Speak: Neutrophils as Biologic Markers of the Inflammatory Response , 1998, Sepsis.
[72] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[73] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[74] J. Rubin,et al. A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration. , 2006, Journal of theoretical biology.
[75] S. Calvano,et al. In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin , 1992, Infection and immunity.
[76] A. Baldwin,et al. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.
[77] A. Aderem,et al. A systems approach to dissecting immunity and inflammation. , 2004, Seminars in immunology.
[78] H. Volk,et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. , 2003, American journal of respiratory and critical care medicine.
[79] T. van der Poll,et al. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.
[80] A. Baldwin,et al. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. , 1995, Science.
[81] J. Briegel,et al. A new role for glucocorticoids in septic shock: balancing the immune response. , 2003, American journal of respiratory and critical care medicine.
[82] Panagiota T. Foteinou,et al. Translational Potential of Systems‐Based Models of Inflammation , 2009, Clinical and translational science.